Back to Home
Online Article

Incorporating Biosimilar Insulin in the Pharmacy: Updates on Interchangeability and the Role of the Pharmacist (Pharmacy Technician Credit)

Release Date

May 31, 2022

Expiration Date

June 1, 2023

Credits

2.0 On-Demand

Topics

Biosimilars, Endocrinology

Add-on activity

This activity includes patient counseling videos.

Program Description

While to date there are a few insulin biosimilars approved for use in patients with diabetes and some undergoing clinical trials, the approval of the first interchangeable insulin biosimilar is an important step in improving access and reducing costs of diabetes management for patients. Pharmacists and pharmacy technicians must be familiar with FDA guidance regarding interchangeability and how the new insulin biosimilar will affect their practice. This program will explore the development, regulatory pathway and approval process, and safety and efficacy considerations for the use of the currently available interchangeable insulin biosimilar in diabetes management. As the role of biosimilars in the care of patients with diabetes continues to expand, pharmacists and pharmacy technicians will be valuable sources of information about these agents and will need to increase awareness about their use among prescribers and patients. This activity includes counseling videos that will cover important counseling pearls for pharmacists to educate health care providers as well as patients on the proper use and role of interchangeable insulin formulations in diabetes treatment and management to improve outcomes and access to care.


Target audience: Pharmacy technician

Type of activity: Application for pharmacists; Knowledge for technicians
Release date: May 31, 2022
Expiration date: May 31, 2023

Time to complete activity: 2 hours
Fee: Free

Educational Objectives

At the completion of this activity, pharmacy technicians will be able to:

  • Review the regulations and approval pathways for biologics and biosimilars
  • Outline requirements for an interchangeable biosimilar
  • Discuss advancements of insulin biosimilars in reducing barriers affecting insulin use, access, and adherence for patients with diabetes
  • Express the role of the pharmacy technician in addressing patient barriers with insulin treatment and referring patients to the pharmacist as appropriate
Incorporating Biosimilar Insulin in the Pharmacy: Updates on Interchangeability and the Role of the Pharmacist (Pharmacy Technician Credit)

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

This activity is supported by an educational grant from Viatris.

What's Included
  • Access your activities anytime, anywhere, with a computer, tablet or smartphone
  • Free access with a PTCE account
  • Pharmacy education designed to improve patient care

Course

Incorporating Biosimilar Insulin in the Pharmacy: Updates on Interchangeability and the Role of the Pharmacist (Pharmacy Technician Credit)

Create Account